LINKER-MM4

Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma

Arms / Cohorts

Experimental, Phase 1:Linvoseltamab: Treatment Naive Patients

Accepting patients

Experimental, Phase 2:Linvoseltamab: Transplant Ineligible Cohort

Not yet accepting

Experimental, Phase 2:Linvoseltamab: Transplant Eligible Cohort

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.